Chapter 2
Multidrug Resistance-Associated Protein (MRP/ABCC Proteins)
Mylène Honorat,
Charles Dumontet,
Lea Payen,
Mylène Honorat
Inserm, U590, Lyon, F-69008, France
Centre Léon Bérard, FNCLCC, Lyon, F-69008, France
Search for more papers by this authorCharles Dumontet
Inserm, U590, Lyon, F-69008, France
Centre Léon Bérard, FNCLCC, Lyon, F-69008, France
Search for more papers by this authorLea Payen
Inserm, U590, Lyon, F-69008, France
Centre Léon Bérard, FNCLCC, Lyon, F-69008, France
Université de Lyon, Laboratoire de Toxicologie, Faculté de Pharmacie, Lyon 1, ISPB, Lyon, F-69008, France
Search for more papers by this authorMylène Honorat,
Charles Dumontet,
Lea Payen,
Mylène Honorat
Inserm, U590, Lyon, F-69008, France
Centre Léon Bérard, FNCLCC, Lyon, F-69008, France
Search for more papers by this authorCharles Dumontet
Inserm, U590, Lyon, F-69008, France
Centre Léon Bérard, FNCLCC, Lyon, F-69008, France
Search for more papers by this authorLea Payen
Inserm, U590, Lyon, F-69008, France
Centre Léon Bérard, FNCLCC, Lyon, F-69008, France
Université de Lyon, Laboratoire de Toxicologie, Faculté de Pharmacie, Lyon 1, ISPB, Lyon, F-69008, France
Search for more papers by this authorBook Editor(s):Ahcène Boumendjel, Jean Boutonnat,
Jacques Robert,
Jean Boutonnat
Institut Jean Roget, Université Joseph Fourier, Grenoble, France
Hôpital Michallon de Grenoble, Grenoble, France
Search for more papers by this authorJacques Robert
Institut Bergonié, Université Victor Segalen, Bordeaux, France
Search for more papers by this authorSeries Editor(s): Binghe Wang,
Binghe Wang
Search for more papers by this authorSummary
This chapter contains sections titled:
-
Introduction
-
Structural similarities among ABCC proteins
-
Endogenous expression levels and physiological functions of ABCC proteins
-
References
REFERENCES
- Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC et al. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650–1654.
- Bakos E, Hegedus T, Hollo Z, Welker E, Tusnady GE, Zaman GJ et al. 1996. Membrane topology and glycosylation of the human multidrug resistance-associated protein. J Biol Chem 271: 12322–12326.
- Frelet A and Klein M. 2006. Insight in eukaryotic ABC transporter function by mutation analysis. FEBS Lett 580: 1064–1084.
- Deeley RG, Westlake C, and Cole SP. 2006. Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86: 849–899.
- Westlake CJ, Cole SP, and Deeley RG. 2005. Role of the NH2-terminal membrane spanning domain of multidrug resistance protein 1/ P-glycoprotein 1 in protein processing and trafficking. Mol Biol Cell 16: 2483–2492.
- Kast C and Gros P. 1997. Topology mapping of the amino-terminal half of multidrug resistance-associated protein by epitope insertion and immunofluorescence. J Biol Chem 272: 26479–26487.
- Kast C and Gros P. 1998. Epitope insertion favors a six transmembrane domain model for the carboxy-terminal portion of the multidrug resistance-associated protein. Biochemistry 37: 2305–2313.
- Bakos E, Evers R, Szakacs G, Tusnady GE, Welker E, Szabo K et al. 1998. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J Biol Chem 273: 32167–32175.
- Hipfner DR, Almquist KC, Leslie EM, Gerlach JH, Grant CE, Deeley RG et al. 1997. Membrane topology of the multidrug resistance protein (MRP). A study of glycosylation-site mutants reveals an extracytosolic NH2 terminus. J Biol Chem 272: 23623–23630.
- Yang Y, Liu Y, Dong Z, Xu J, Peng H, Liu Z et al. 2007. Regulation of function by dimerization through the amino-terminal membrane-spanning domain of human ABCC1/MRP1. J Biol Chem 282: 8821–8830.
- Daoud R, Desneves J, Deady LW, Tilley L, Scheper RJ, Gros P et al. 2000. The multidrug resistance protein is photoaffinity labeled by a quinoline-based drug at multiple sites. Biochemistry 39: 6094–6102.
- Daoud R, Julien M, Gros P, and Georges E. 2001. Major photoaffinity drug binding sites in multidrug resistance protein 1 (MRP1) are within transmembrane domains 10-11 and 16-17. J Biol Chem 276: 12324–12330.
- Daoud R, Kast C, Gros P, and Georges E. 2000. Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1). Biochemistry 39: 15344–15352.
- Haimeur A, Conseil G, Deeley RG, and Cole SP. 2004. Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1). Mol Pharmacol 65: 1375–1385.
- Haimeur A, Deeley RG, and Cole SP. 2002. Charged amino acids in the sixth transmembrane helix of multidrug resistance protein 1 (MRP1/ABCC1) are critical determinants of transport activity. J Biol Chem 277: 41326–41333.
- Mao Q, Qiu W, Weigl KE, Lander PA, Tabas LB, Shepard RL et al. 2002. GSH-dependent photolabeling of multidrug resistance protein MRP1 (ABCC1) by [125I]LY475776. Evidence of a major binding site in the COOH-proximal membrane spanning domain. J Biol Chem 277: 28690–28699.
- Zhang DW, Cole SP, and Deeley RG. 2001. Identification of an amino acid residue in multidrug resistance protein 1 critical for conferring resistance to anthracyclines. J Biol Chem 276: 13231–13239.
- Zhang DW, Cole SP, and Deeley RG. 2001. Identification of a nonconserved amino acid residue in multidrug resistance protein 1 important for determining substrate specificity: Evidence for functional interaction between transmembrane helices 14 and 17. J Biol Chem 276: 34966–34974.
- Zhang DW, Cole SP, and Deeley RG. 2002. Determinants of the substrate specificity of multidrug resistance protein 1: Role of amino acid residues with hydrogen bonding potential in predicted transmembrane helix 17. J Biol Chem 277: 20934–20941.
- Zhang DW, Gu HM, Vasa M, Muredda M, Cole SP, and Deeley RG. 2003. Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3. Biochemistry 42: 9989–10000.
- Zhang DW, Gu HM, Situ D, Haimeur A, Cole SP, and Deeley RG. 2003. Functional importance of polar and charged amino acid residues in transmembrane helix 14 of multidrug resistance protein 1 (MRP1/ABCC1): Identification of an aspartate residue critical for conversion from a high to low affinity substrate binding state. J Biol Chem 278: 46052–46063.
- Qian YM, Grant CE, Westlake CJ, Zhang DW, Lander PA, Shepard RL et al. 2002. Photolabeling of human and murine multidrug resistance protein 1 with the high affinity inhibitor [125I]LY475776 and azidophenacyl-[35S]glutathione. J Biol Chem 277: 35225–35231.
- Situ D, Haimeur A, Conseil G, Sparks KE, Zhang D, Deeley RG et al. 2004. Mutational analysis of ionizable residues proximal to the cytoplasmic interface of membrane spanning domain 3 of the multidrug resistance protein, MRP1 (ABCC1): Glutamate 1204 is important for both the expression and catalytic activity of the transporter. J Biol Chem 279: 38871–38880.
- Zhang DW, Nunoya K, Vasa M, Gu HM, Theis A, Cole SP et al. 2004. Transmembrane helix 11 of multidrug resistance protein 1 (MRP1/ABCC1): Identification of polar amino acids important for substrate specificity and binding of ATP at nucleotide binding domain 1. Biochemistry 43: 9413–9425.
- Zhang DW, Nunoya K, Vasa M, Gu HM, Cole SP, and Deeley RG. 2006. Mutational analysis of polar amino acid residues within predicted transmembrane helices 10 and 16 of multidrug resistance protein 1 (ABCC1): Effect on substrate specificity. Drug Metab Dispos 34: 539–546.
- Smith PC, Karpowich N, Millen L, Moody JE, Rosen J, Thomas PJ et al. 2002. ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell 10: 139–149.
- Locher KP, Lee AT, and Rees DC. 2002. The E. coli BtuCD structure: A framework for ABC transporter architecture and mechanism. Science 296: 1091–1098.
- Chen J, Lu G, Lin J, Davidson AL, and Quiocho FA. 2003. A tweezers-like motion of the ATP-binding cassette dimer in an ABC transport cycle. Mol Cell 12: 651–661.
- Diederichs K, Diez J, Greller G, Müller C, Breed J, Schnell C et al. 2000. Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis. EMBO J 19: 5951–5961.
- Gaudet R and Wiley DC. 2001. Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing. EMBO J 20: 4964–4972.
- Hung LW, Wang IX, Nikaido K, Liu PQ, Ames GF, and Kim SH. 1998. Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 396: 703–707.
- Linton KJ and Higgins CF. 2007. Structure and function of ABC transporters: The ATP switch provides flexible control. Pflugers Arch 453: 555–567.
- Sauna ZE and Ambudkar SV. 2007. About a switch: How P-glycoprotein (ABCB1) harnesses the energy of ATP binding and hydrolysis to do mechanical work. Mol Cancer Ther 6: 13–23.
- Higgins CF and Linton KJ. 2004. The ATP switch model for ABC transporters. Nat Struct Mol Biol 11: 918–926.
- Gao M, Cui HR, Loe DW, Grant CE, Almquist KC, Cole SP et al. 2000. Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1. J Biol Chem 275: 13098–13108.
- Hou Y, Cui L, Riordan JR, and Chang X. 2000. Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1. J Biol Chem 275: 20280–20287.
- Buyse F, Hou YX, Vigano C, Zhao Q, Ruysschaert JM, and Chang XB. 2006. Replacement of the positively charged Walker A lysine residue with a hydrophobic leucine residue and conformational alterations caused by this mutation in MRP1 impair ATP binding and hydrolysis. Biochem J 397: 121–130.
- Yang R, Scavetta R, and Chang XB. 2008. The hydroxyl group of S685 in Walker A motif and the carboxyl group of D792 in Walker B motif of NBD1 play a crucial role for multidrug resistance protein folding and function. Biochim Biophys Acta 1778: 454–465.
- Payen LF, Gao M, Westlake CJ, Cole SP, and Deeley RG. 2003. Role of carboxylate residues adjacent to the conserved core Walker B motifs in the catalytic cycle of multidrug resistance protein 1 (ABCC1). J Biol Chem 278: 38537–38547.
- Yang R, McBride A, Hou YX, Goldberg A, and Chang XB. 2005. Nucleotide dissociation from NBD1 promotes solute transport by MRP1. Biochim Biophys Acta 1668: 248–261.
- Yang R and Chang XB. 2007. Hydrogen-bond formation of the residue in H-loop of the nucleotide binding domain 2 with the ATP in this site and/or other residues of multidrug resistance protein MRP1 plays a crucial role during ATP-dependent solute transport. Biochim Biophys Acta 1768: 324–335.
- Hopper E, Belinsky MG, Zeng H, Tosolini A, Testa JR, and Kruh GD. 2001. Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Lett 162: 181–191.
- Bera TK, Lee S, Salvatore G, Lee B, and Pastan I. 2001. MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med 7: 509–516.
- Yabuuchi H, Shimizu H, Takayanagi S, and Ishikawa T. 2001. Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochem Biophys Res Commun 288: 933–939.
- Tammur J, Prades C, Arnould I, Rzhetsky A, Hutchinson A, Adachi M et al. 2001. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 273: 89–96.
- Yabuuchi H, Takayanagi S, Yoshinaga K, Taniguchi N, Aburatani H, and Ishikawa T. 2002. ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. Biochem Biophys Res Commun 299: 410–417.
- Annilo T and Dean M. 2004. Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. Genomics 84: 34–46.
- Haimeur A, Conseil G, Deeley RG, and Cole SP. 2004. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation. Curr Drug Metab 5: 21–53.
- Payen L, Sparfel L, Courtois A, Vernhet L, Guillouzo A, and Fardel O. 2002. The drug efflux pump MRP2: Regulation of expression in physiopathological situations and by endogenous and exogenous compounds. Cell Biol Toxicol 18: 221–233.
- Catania VA, Sánchez Pozzi EJ, Luquita MG, Ruiz ML, Villanueva SS, Jones B et al. 2004. Co-regulation of expression of phase II metabolizing enzymes and multidrug resistance-associated protein 2. Ann Hepatol 3(1): 11–17.
- Fromm MF. 2002. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv Drug Deliv Rev 54: 1295–1310.
- van de Water FM, Masereeuw R, and Russel FG. 2005. Function and regulation of multidrug resistance proteins (MRPs) in the renal elimination of organic anions. Drug Metab Rev 37: 443–471.
- Mayer R, Kartenbeck J, Büchler M, Jedlitschky G, Leier I, and Keppler D. 1995. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J Cell Biol 131: 137–150.
- Peng KC, Cluzeaud F, Bens M, Van Huyen JP, Wioland MA, Lacave R et al. 1999. Tissue and cell distribution of the multidrug resistance-associated protein (MRP) in mouse intestine and kidney. J Histochem Cytochem 47: 757–768.
- Pei QL, Kobayashi Y, Tanaka Y, Taguchi Y, Higuchi K, Kaito M et al. 2002. Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats. Hepatol Res 22: 58–64.
- Scheffer GL, Kool M, de Haas M, de Vree JM, Pijnenborg AC, Bosman DK et al. 2002. Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 82: 193–201.
- Nies AT, Jedlitschky G, Konig J, Herold-Mende C, Steiner HH, Schmitt HP et al. 2004. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129: 349–360.
- Lorico A, Rappa G, Finch RA, Yang D, Flavell RA, and Sartorelli AC. 1997. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res 57: 5238–5242.
- Versantvoort CH, Broxterman HJ, Bagrij T, Scheper RJ, and Twentyman PR. 1995. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 72: 82–89.
- Versantvoort CH, Bagrij T, Wright KA, and Twentyman PR. 1995. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int J Cancer 63: 855–862.
- Cole SP and Deeley RG. 2006. Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol Sci 27: 438–446.
- Franco R and Cidlowski JA. 2006. SLCO/OATP-like transport of glutathione in FasL-induced apoptosis: Glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis. J Biol Chem 281: 29542–29557.
- Hammond CL, Marchan R, Krance SM, and Ballatori N. 2007. Glutathione export during apoptosis requires functional multidrug resistance-associated proteins. J Biol Chem 282: 14337–14347.
- Trompier D, Chang XB, Barattin R, du Moulinet D'Hardemare A, Di Pietro A, and Baubichon-Cortay H. 2004. Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1. Cancer Res 64: 4950–4956.
- Perrotton T, Trompier D, Chang XB, Di Pietro A, and Baubichon-Cortay H. 2007. (R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1. J Biol Chem 282: 31542–31548.
- Wijnholds J, Evers R, van Leusden MR, Mol CA, Zaman GJ, and Mayer U et al. 1997. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med 3: 1275–1279.
- van der Deen M, Timens W, Timmer-Bosscha H, van der Strate BW, Scheper RJ, Postma DS et al. 2007. Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice. Respir Res 8: 49–65.
- Lee G and Piquette-Miller M. 2001. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol 79: 876–884.
- Lickteig AJ, Slitt AL, Arkan MC, Karin M, and Cherrington NJ. 2007. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos 35: 402–409.
- Dreuw A, Hermanns HM, Heise R, Joussen S, Rodriguez F, Marquardt Y et al. 2005. Interleukin-6-type cytokines upregulate expression of multidrug resistance-associated proteins in NHEK and dermal fibroblasts. J Invest Dermatol 124: 28–37.
- Evers R, Cnubben NH, Wijnholds J, van Deemter L, van Bladeren PJ, and Borst P. 1997. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Lett 419: 112–116.
- Reid G, Wielinga P, Zelcer N, van der Heijden I, Kuil A, de Haas M et al. 2003. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal anti-inflammatory drugs. Proc Natl Acad Sci U S A 100: 9244–9249.
- Lin ZP, Zhu YL, Johnson DR, Rice KP, Nottoli T, Hains BC et al. 2008. Disruption of cAMP and PGE2 transport by Mrp4 deficiency alters cAMP-mediated signaling and nociceptive response. Mol Pharmacol 73: 243–251.
- Bernard C, Merval R, Lebret M, Delerive P, Dusanter-Fourt I, Lehoux S et al. 1999. Onconstatin M induces interleukin-6 and cyclooxygenase-2 expression in human vascular smooth muscle cells: Synergy with interleukin-1beta. Circ Res 85: 1124–1131.
- Repovic P, Mi K, and Benveniste EN. 2003. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: Synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide. Glia 42: 433–446.
- Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, and Randolph GJ. 2000. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103: 757–768.
- Kyle-Cezar F, Echevarria-Lima J, and Rumjanek VM. 2007. Independent regulation of ABCB1 and ABCC activities in thymocytes and bone marrow mononuclear cells during aging. Scand J Immunol 66: 238–248.
- Ros JE, Libbrecht L, Geuken M, Jansen PL, and Roskams TA. 2003. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J Pathol 200: 553–560.
- Vos TA, Ros JE, Havinga R, Moshage H, Kuipers F, Jansen PL et al. 1999. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology 29: 1833–1839.
- Roelofsen H, Hooiveld GJ, Koning H, Havinga R, Jansen PL, and Muller M. 1999. Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein. J Cell Sci 112 (Pt 9): 1395–1404.
- Buchler M, Konig J, Brom M, Kartenbeck J, Spring H, Horie T et al. 1996. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 271: 15091–15098.
- Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M et al. 1996. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56: 4124–4129.
- van Kuijck MA, van Aubel RA, Busch AE, Lang F, Russel FG, Bindels RJ et al. 1996. Molecular cloning and expression of a cyclic AMP-activated chloride conductance regulator: A novel ATP-binding cassette transporter. Proc Natl Acad Sci U S A 93: 5401–5406.
- Fritz F, Chen J, Hayes P, and Sirotnak FM. 2000. Molecular cloning of the murine cMOAT ATPase. Biochim Biophys Acta 1492: 531–536.
- Conrad S, Viertelhaus A, Orzechowski A, Hoogstraate J, Gjellan K, Schrenk D et al. 2001. Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1. Toxicology 156: 81–91.
- Keppler D and Konig J. 1997. Hepatic canalicular membrane 5: Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J 11: 509–516.
- Schaub TP, Kartenbeck J, Konig J, Vogel O, Witzgall R, Kriz W et al. 1997. Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 8: 1213–1221.
- Schaub TP, Kartenbeck J, Konig J, Spring H, Dorsam J, Staehler G et al. 1999. Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma. J Am Soc Nephrol 10: 1159–1169.
- Mottino AD, Hoffman T, Jennes L, and Vore M. 2000. Expression and localization of multidrug resistant protein mrp2 in rat small intestine. J Pharmacol Exp Ther 293: 717–723.
- Rost D, Mahner S, Sugiyama Y, and Stremmel W. 2002. Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. Am J Physiol Gastrointest Liver Physiol 282: 720–726.
- Rost D, Konig J, Weiss G, Klar E, Stremmel W, and Keppler D. 2001. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology 121: 1203–1208.
- Hoffmann K, Gastens AM, Volk HA, and Loscher W. 2006. Expression of the multidrug transporter MRP2 in the blood-brain barrier after pilocarpine-induced seizures in rats. Epilepsy Res 69: 1–14.
- Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H et al. 2001. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 299: 164–170.
- Cherrington NJ, Hartley DP, Li N, Johnson DR, and Klaassen CD. 2002. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 300: 97–104.
- Oselin K, Mrozikiewicz PM, Pahkla R, and Roots I. 2003. Quantitative determination of the human MRP1 and MRP2 mRNA expression in FACS-sorted peripheral blood CD4+, CD8+, CD19+, and CD56+ cells. Eur J Haematol 71: 119–123.
- Schinkel AH and Jonker JW. 2003. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview. Adv Drug Deliv Rev 55: 3–29.
- Surowiak P, Materna V, Kaplenko I, Spaczynski M, Dolinska-Krajewska B, Gebarowska E et al. 2006. ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome. Clin Cancer Res 12: 7149–7158.
- Tomer G, Ananthanarayanan M, Weymann A, Balasubramanian N, and Suchy FJ. 2003. Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Pediatr Res 53: 288–294.
- Ros JE, Roskams TA, Geuken M, Havinga R, Splinter PL, and Petersen BE. 2003. ATP binding cassette transporter gene expression in rat liver progenitor cells. Gut 52: 1060–1067.
- Cao J, Stieger B, Meier PJ, and Vore M. 2002. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. Am J Physiol Gastrointest Liver Physiol 283: 757–766.
- Mottino AD, Hoffman T, Jennes L, Cao J, and Vore M. 2001. Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats. Am J Physiol Gastrointest Liver Physiol 280: G1261–G1273.
- St-Pierre MV, Serrano MA, Macias RI, Dubs U, Hoechli M, Lauper U et al. 2000. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 279: R1495–R1503.
- Hashimoto K, Uchiumi T, Konno T, Ebihara T, Nakamura T, Wada M et al. 2002. Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome. Hepatology 36: 1236–1245.
- Kajihara S, Hisatomi A, Mizuta T, Hara T, Ozaki I, Wada I et al. 1998. A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome. Biochem Biophys Res Commun 253: 454–457.
- Keitel V, Kartenbeck J, Nies AT, Spring H, Brom M, and Keppler D. 2000. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 32: 1317–1328.
- Mor-Cohen R, Zivelin A, Rosenberg N, Shani M, Muallem S, and Seligsohn U. 2001. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J Biol Chem 276: 36923–36930.
- Paulusma CC, Kool M, Bosma PJ, Scheffer GL, ter Borg F, Scheper RJ et al. 1997. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 25: 1539–1542.
- Shoda J, Suzuki H, Suzuki H, Sugiyama Y, Hirouchi M, Utsunomiya H et al. 2003. Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome. Hepatol Res 27: 323–326.
- Tate G, Li M, Suzuki T, and Mitsuya T. 2002. A new mutation of the ATP-binding cassette, sub-family C, member 2 (ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome. Genes Genet Syst 77: 117–121.
- Toh S, Wada M, Uchiumi T, Inokuchi A, Makino Y, Horie Y et al. 1999. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am J Hum Genet 64: 739–746.
- Tsujii H, König J, Rost D, Stöckel B, Leuschner U, and Keppler D. 1999. Exonintron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. Gastroenterology 117: 653–660.
- Wada M, Toh S, Taniguchi K, Nakamura T, Uchiumi T, Kohno K et al. 1998. Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet 7: 203–207.
- Wakusawa S, Machida I, Suzuki S, Hayashi H, Yano M, and Yoshioka K. 2003. Identification of a novel 2026G→C mutation of the MRP2 gene in a Japanese patient with Dubin-Johnson syndrome. J Hum Genet 48: 425–429.
- König J, Rost D, Cui Y, and Keppler D. 1999. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29: 1156–1163.
- Muller M and Jansen PL. 1997. Molecular aspects of hepatobiliary transport. Am J Physiol 272: G1285–G1303.
- Chu XY, Strauss JR, Mariano MA, Li J, Newton DJ, Cai X et al. 2006. Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2). J Pharmacol Exp Ther 317: 579–589.
- Vlaming ML, Mohrmann K, Wagenaar E, de Waart DR, Elferink RP, Lagas JS et al. 2006. Carcinogen and anticancer drug transport by Mrp2 in vivo: Studies using Mrp2 (Abcc2) knockout mice. J Pharmacol Exp Ther 318: 319–327.
- Nezasa K, Tian X, Zamek-Gliszczynski MJ, Patel NJ, Raub TJ et al. 2006. Altered hepatobiliary disposition of 5 (and 6)-carboxy-2′,7′-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice. Drug Metab Dispos 34: 718–723.
- Huang L, Smit JW, Meijer DK, and Vore M. 2000. Mrp2 is essential for estradiol-17-beta(D-glucuronide)-induced cholestasis in rats. Hepatology 32: 66–72.
- Rost D, Kartenbeck J, and Keppler D. 1999. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology 29: 814–821.
- Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF et al. 1997. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology 113: 255–264.
- Vos TA, Hooiveld GJ, Koning H, Childs S, Meijer DK, Moshage H et al. 1998. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28: 1637–1644.
- Ruiz ML, Villanueva SS, Luquita MG, Vore M, Mottino AD, and Catania VA. 2006. Ethynylestradiol increases expression and activity of rat liver MRP3. Drug Metab Dispos 34: 1030–1034.
- Cao J, Huang L, Liu Y, Hoffman T, Stieger B, Meier PJ et al. 2001. Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin. Hepatology 33: 140–147.
- Demeule M, Jodoin J, Beaulieu E, Brossard M, and Beliveau R. 1999. Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett 442: 208–214.
- Courtois A, Payen L, Guillouzo A, and Fardel O. 1999. Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone. FEBS Lett 459: 381–385.
- Turncliff RZ, Meier PJ, and Brouwer KL. 2004. Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes. Drug Metab Dispos 32: 834–839.
- Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM et al. 2002. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277: 2908–2915.
- Dussault I, Lin M, Hollister K, Wang EH, Synold TW, and Forman BM. 2001. Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR. J Biol Chem 276: 33309–33312.
- Fromm MF, Kauffmann HM, Fritz P, Burk O, Kroemer HK, Warzok RW et al. 2000. The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol 157: 1575–1580.
- Hirohashi T, Suzuki H, and Sugiyama Y. 1999. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem 274: 15181–15185.
- Kiuchi Y, Suzuki H, Hirohashi T, Tyson CA, and Sugiyama Y. 1998. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3). FEBS Lett 433: 149–152.
- Kiuchi Y, Dawson PA, and Sugiyama Y. 2005. Analysis of the in vivo functions of Mrp3. FEBS Lett 68: 160–168.
- Uchiumi T, Hinoshita E, Haga S, Nakamura T, Tanaka T, Toh S et al. 1998. Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. Biochem Biophys Res Commun 252: 103–110.
- Maher JM, Slitt AL, Cherrington NJ, Cheng X, and Klaassen CD. 2005. Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab Dispos 33: 947–955.
- Shoji T, Suzuki H, Kusuhara H, Watanabe Y, Sakamoto S, and Sugiyama Y. 2004. ATP-dependent transport of organic anions into isolated basolateral membrane vesicles from rat intestine. Am J Physiol Gastrointest Liver Physiol 287: 749–756.
- Hirohashi T, Suzuki H, Takikawa H, and Sugiyama Y. 2000. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem 275: 2905–2910.
- Kool M, van der Linden M, de Haas M, Scheffer GL, de Vree JM, Smith AJ et al. 1999. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A 96: 6914–6919.
- Soroka CJ, Lee JM, Azzaroli F, and Boyer JL. 2001. Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33: 783–791.
- Ballestero MR, Monte MJ, Briz O, Jimenez F, Gonzalez-San Martin F, and Marin JJ. 2006. Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps. Biochem Pharmacol 72: 729–738.
- Zimmermann C, Gutmann H, Hruz P, Gutzwiller JP, Beglinger C, and Drewe J. 2005. Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract. Drug Metab Dispos 33: 219–224.
- Kuroda M, Kobayashi Y, Tanaka Y, Itani T, Mifuji R, Araki J et al. 2004. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats. J Gastroenterol Hepatol 19: 146–153.
- Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T et al. 1998. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol 53: 1068–1075.
- Slitt AL, Cherrington NJ, Maher JM, and Klaassen CD. 2003. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Drug Metab Dispos 31: 1176–1186.
- Trauner M and Boyer JL. 2003. Bile salt transporters: Molecular characterization, function, and regulation. Physiol Rev 83: 633–671.
- Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V et al. 2005. Analysis of the in vivo functions of Mrp3. Mol Pharmacol 68: 160–168.
- Zelcer N, van de Wetering K, de Waart R, Scheffer GL, Marschall HU, Wielinga PR et al. 2006. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J Hepatol 44: 768–775.
- Andric SA, Kostic TS, and Stojilkovic SS. 2006. Contribution of multidrug resistance protein MRP5 in control of cyclic guanosine 5′-monophosphate intracellular signaling in anterior pituitary cells. Endocrinology 147: 3435–3445.
- Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA et al. 1997. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 57: 3537–3547.
- Lee K, Belinsky MG, Bell DW, Testa JR, and Kruh GD. 1998. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res 58: 2741–2747.
- Chen C and Klaassen CD. 2004. Rat multidrug resistance protein 4 (Mrp4, Abcc4): Molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. Biochem Biophys Res Commun 317: 46–53.
- Schuetz JD, Connelly MC, Sun D, Paibir SG, Flynn PM, Srinivas RV et al. 1999. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat Med 5: 1048–1051.
- Chen ZS, Lee K, and Kruh GD. 2001. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J Biol Chem 276: 33747–33754.
- Lai L and Tan TM. 2002. Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J 361: 497–503.
- Wielinga PR, Reid G, Challa EE, van der Heijden I, van Deemter L, de Haas M et al. 2002. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol 62: 1321–1331.
- Wielinga PR, van der Heijden I, Reid G, Beijnen JH, Wijnholds J, and Borst P. 2003. Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells. J Biol Chem 278: 17664–17671.
- Reid G, Wielinga P, Zelcer N, De Haas M, Van Deemter L, Wijnholds J et al. 2003. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol Pharmacol 63: 1094–1103.
- Imaoka T, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, and Sugiyama Y. 2007. Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol 71: 619–627.
- van Aubel RA, Smeets PH, Peters JG, Bindels RJ, and Russel FG. 2002. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: Putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol 13: 595–603.
- Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G et al. 2004. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol 24: 7612–7621.
- Lee K, Klein-Szanto AJ, and Kruh GD. 2000. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. J Natl Cancer Inst 92: 1934–1940.
- Rius M, Nies AT, Hummel-Eisenbeiss J, Jedlitschky G, and Keppler D. 2003. Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38: 374–384.
- Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD, and Borst P. 2003. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J 371: 361–367.
- Belinsky MG, Guo P, Lee K, Zhou F, Kotova E, Grinberg A et al. 2007. Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage. Cancer Res 67: 262–268.
- Belinsky MG, Bain LJ, Balsara BB, Testa JR, and Kruh GD. 1998. Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. J Natl Cancer Inst 90: 1735–1741.
- Meyer Zu Schwabedissen HE, Grube M, Heydrich B, Linnemann K, Fusch C, Kroemer HK et al. 2005. Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: Effects of gestational age and cellular differentiation. Am J Pathol 166: 39–48.
- Suzuki T, Sasaki H, Kuh HJ, Agui M, Tatsumi Y, Tanabe S et al. 2000. Detailed structural analysis on both human MRP5 and mouse mrp5 transcripts. Gene 242: 167–173.
- Maher JM, Cherrington NJ, Slitt AL, and Klaassen CD. 2006. Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6. Life Sci 78: 2219–2225.
- McAleer MA, Breen MA, White NL, and Matthews N. 1999. pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells. J Biol Chem 274: 23541–23548.
- Jedlitschky G, Burchell B, and Keppler D. 2000. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem 275: 30069–30074.
- Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F et al. 2000. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A 97: 7476–7481.
- Madon J, Hagenbuch B, Landmann L, Meier PJ, and Stieger B. 2000. Transport function and hepatocellular localization of mrp6 in rat liver. Mol Pharmacol 57: 634–641.
- Scheffer GL, Hu X, Pijnenborg AC, Wijnholds J, Bergen AA, and Scheper RJ. 2002. MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest 82: 515–518.
- Beck K, Hayashi K, Nishiguchi B, Le Saux O, Hayashi M, and Boyd CD. 2003. The distribution of Abcc6 in normal mouse tissues suggests multiple functions for this ABC transporter. J Histochem Cytochem 51: 887–902.
- Sinko E, Ilias A, Ujhelly O, Homolya L, Scheffer GL, Bergen AA et al. 2003. Subcellular localization and N-glycosylation of human ABCC6, expressed in MDCKII cells. Biochem Biophys Res Commun 308: 263–269.
- Belinsky MG and Kruh GD. 1999. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br J Cancer 80: 1342–1349.
- Hu X, et al. 2003. Analysis of the frequent R1141X mutation in the ABCC6 gene in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci 44 (5): 1824–1829.
- Hu X, Plomp A, Wijnholds J, Ten Brink J, van Soest S, van den Born LI et al. 2003. ABCC6/MRP6 mutations: Further insight into the molecular pathology of pseudoxanthoma elasticum. Eur J Hum Genet 11: 215–224.
- Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, and Kruh GD. 2002. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res 62: 6172–6177.
- Bergen AA, Plomp AS, Hu X, de Jong PT, and Gorgels TG. 2007. ABCC6 and pseudoxanthoma elasticum. Pflugers Arch 453: 685–691.
- Gorgels TG, Hu X, Scheffer GL, van der Wal AC, Toonstra J, de Jong PT et al. 2005. Disruption of Abcc6 in the mouse: Novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 14: 1763–1773.
- Li Q, Jiang Q, and Uitto J. 2008. Pseudoxanthoma elasticum: Oxidative stress and antioxidant diet in a mouse model (Abcc6(−/−). J Invest Dermatol 128: 1160–1164.
- Chen ZS, et al. 2003. Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Mol Pharmacol 63 (2): 351–358.
- Kao HH, Chang MS, Cheng JF, and Huang JD. 2003. Genomic structure, gene expression, and promoter analysis of human multidrug resistance-associated protein 7. J Biomed Sci 10: 98–110.
- Takayanagi S, Kataoka T, Ohara O, Oishi M, Kuo MT, and Ishikawa T. 2004. Human ATP-binding cassette transporter ABCC10: Expression profile and p53-dependent upregulation. J Exp Ther Oncol 4: 239–246.
- Augustine LM, Markelewicz RJ, Jr., Boekelheide K, and Cherrington NJ. 2005. Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier. Drug Metab Dispos 33: 182–189.
- Kruh GD, Guo Y, Hopper-Borge E, Belinsky MG, and Chen ZS. 2007. ABCC10, ABCC11, and ABCC12. Pflugers Arch 453: 675–684.
- Hopper-Borge E, Chen ZS, Shchaveleva I, Belinsky MG, and Kruh GD. 2004. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): Resistance to docetaxel. Cancer Res 64: 4927–4930.
- Naramoto H, Uematsu T, Uchihashi T, Doto R, Matsuura T, Usui Y et al. 2007. Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines. Int J Oncol 30: 393–401.
- Bortfeld M, Rius M, Konig J, Herold-Mende C, Nies AT, and Keppler D. 2006. Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience 137: 1247–1257.
- Shimizu H, Taniguchi H, Hippo Y, Hayashizaki Y, Aburatani H, and Ishikawa T. 2003. Characterization of the mouse Abcc12 gene and its transcript encoding an ATP-binding cassette transporter, an orthologue of human ABCC12. Gene 310: 17–28.
- Chen ZS, Guo Y, Belinsky MG, Kotova E, and Kruh GD. 2005. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol Pharmacol 67: 545–557.
- Honorat M, Mesnier A, Vendrell J, Guitton J, Bieche I, Lidereau R et al. 2008. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in Tamoxifen-resistant breast cancer cells. Endocr Relat Cancer 15: 125–138.
- Du T, Feng B, Wang X, Mao W, Zhu X, and Li L et al. 2008. Localization and mutation detection for paroxysmal kinesigenic choreoathetosis. J Mol Neurosci 34: 101–107.
- Yoshiura K, Kinoshita A, Ishida T, Ninokata A, Ishikawa T, Kaname T et al. 2006. A SNP in the ABCC11 gene is the determinant of human earwax type. Nat Genet 38: 324–330.
- Miura K, Yoshiura K, Miura S, Shimada T, Yamasaki K, Yoshida A et al. 2007. A strong association between human earwax-type and apocrine colostrum secretion from the mammary gland. Hum Genet 121: 631–633.
- Vendrell JA, Magnino F, Danis E, Duchesne MJ, Pinloche S, Pons M et al. 2004. Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol 32: 397–414.
- Bera TK, Iavarone C, Kumar V, Lee S, Lee B, and Pastan I. 2002. MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. Proc Natl Acad Sci U S A 99: 6997–7002.
